Christine M. Simmon

Christine Simmon is currently the President & CEO at Food and Drug Law Institute (FDLI) since July 2022. Before this role, she was the Co-Founder & Executive Director at The Biosimilars Council from April 2015 to June 2022. Furthermore, she held the position of Executive Vice President, Policy & Strategic Alliances at Association for Accessible Medicines from October 2012 to June 2022. Prior to her work at FDLI, she served as the Senior Director Public Policy & Issues Management at CVS Health from May 2008 to October 2012. Additionally, she worked as the VP Policy, Public Affairs & Development at Generic Pharmaceutical Association from November 2002 to March 2006. Christine completed her Juris Doctor (J.D.) from Georgetown University Law Center and earned a Bachelor’s Degree in American Studies from Georgetown University.